Glenmark Pharmaceuticals has informed that a meeting of the Board of Directors of the company will be held on January 24, 2014, to consider and approve the Company Un-audited Financial Statements for the Third Quarter ended December 31, 2013.
The above information is a part of company’s filings submitted to BSE.